论文部分内容阅读
关于对住院危重糖尿病患者进行强化血糖控制的问题存在争议。大部分采用胰岛素治疗的结果令人失望。在这次辩论中,我们主张使用GLP-1类似物,并将给出支持证据,它们能够有效控制应激性高血糖,而且副作用很少,尤其是低血糖。住院患者血糖控制不佳预示死亡率增加无论是非危重内科/外科患者还是在重症监护病房的患者,高血糖都是常见的症状,超过30%~50%的病人会出现这一症状。高血糖是院内患者死亡率的独立危险指标。不管有无糖尿病病
There is controversy over the question of intensive glycemic control of critically ill diabetic patients in hospital. Most of the results of insulin treatment disappointing. In this debate, we advocate the use of GLP-1 analogues and will provide supporting evidence that they can effectively control stress hyperglycemia with few side effects, especially hypoglycaemia. Inadequate glycemic control in hospitalized patients predicts increased mortality Hyperglycemia is a common symptom in patients who are not in critical medical / surgical settings or in intensive care units. This condition occurs in more than 30% to 50% of patients. Hyperglycemia is an independent risk indicator of in-hospital mortality. No matter whether there is diabetes or not